Breaking News Instant updates and real-time market news.

MGTX

MeiraGTx

$29.00

0.93 (3.31%)

17:39
07/02/19
07/02
17:39
07/02/19
17:39

MeiraGTx files to sell 5.8M ordinary shares for holders

MGTX MeiraGTx
$29.00

0.93 (3.31%)

07/09/18
EVER
07/09/18
INITIATION
Target $21
EVER
Outperform
MeiraGTx initiated with an Outperform at Evercore ISI
Evercore ISI analyst Steven Breazzano initiated MeiraGTx with an Outperform and $21 price target.
08/23/18
CHDN
08/23/18
INITIATION
Target $30
CHDN
Buy
MeiraGTx initiated with a Buy at Chardan
Chardan analyst Gbola Amusa initaited MeiraGTx with a Buy and $30 price target saying the company is "primed" for significant long-term returns as its ocular, salivary, and neurodegenerative diseases franchises contribute to the broader arrival of AAV-based gene therapy. Amusa is forecasting $1.1B in risk adjusted 2028 estimated sales, making MeiraGTx a hing-conviction pick in AAV-based gene therapy coverage.
02/27/19
CHDN
02/27/19
NO CHANGE
Target $40
CHDN
Buy
MeiraGTx price target raised to $40 from $30 at Chardan
Chardan analyst Gbola Amusa raised his price target for MeiraGTx Holdings (MGTX) to $40 from $30 following Johnson & Johnson's equity stake in the company. MeiraGTx , a top pick for 2019 at Chardan, announced a strategic collaboration on inherited retinal diseases with J&J's Janssen Pharmaceuticals and an $80M private placement, with the investment arm of J&J taking a $40M stake, Amusa tells investors in a research note. The news represents the third announced collaboration or investment by a J&J vehicle in MeiraGTx, the analyst points out. This may signal potential takeover interest by J&J longer term and suggests the pharma giant sees significant value in the inherited retinal diseases market opportunities, contends Amusa. He keeps a Buy rating on MeiraGTx.
05/15/19
LEHM
05/15/19
NO CHANGE
Target $30
LEHM
Overweight
MeiraGTx price target raised to $30 from $20 at Barclays
Barclays analyst Gena Wang raised her price target for MeiraGTx Holdings to $30 from $20 saying the company reported positive topline data from the AAV-RPE65 Phase 1/2 study together with its Q1 earnings release. The analyst views the data as proof of concept for MeiraGTx's franchise in inherited retinal diseases and she expects some positive read through to the company's other IRD programs. Wang reiterates an Overewight rating on the shares.

TODAY'S FREE FLY STORIES

XPO

XPO Logistics

$84.16

-0.45 (-0.53%)

06:19
11/12/19
11/12
06:19
11/12/19
06:19
Recommendations
XPO Logistics analyst commentary  »

Citi sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$218.99

-3.93 (-1.76%)

, AAPL

Apple

$262.16

1.96 (0.75%)

06:18
11/12/19
11/12
06:18
11/12/19
06:18
Periodicals
Goldman to let Apple Card customers appearl credit limit, BI reports »

Goldman Sachs (GS) will…

GS

Goldman Sachs

$218.99

-3.93 (-1.76%)

AAPL

Apple

$262.16

1.96 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CWK

Cushman & Wakefield

$18.92

0.24 (1.28%)

06:16
11/12/19
11/12
06:16
11/12/19
06:16
Syndicate
Cushman & Wakefield files to sell 10M ordinary shares for holders »

Morgan Stanley is serving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBM

Hudbay Minerals

$3.66

-0.09 (-2.40%)

06:16
11/12/19
11/12
06:16
11/12/19
06:16
Downgrade
Hudbay Minerals rating change  »

Hudbay Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

RETA

Reata Pharmaceuticals

$213.52

1.48 (0.70%)

06:15
11/12/19
11/12
06:15
11/12/19
06:15
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

OII

Oceaneering

$13.99

-0.29 (-2.03%)

06:13
11/12/19
11/12
06:13
11/12/19
06:13
Initiation
Oceaneering initiated  »

Oceaneering resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGT

Allegiant Travel

$169.97

1.81 (1.08%)

06:12
11/12/19
11/12
06:12
11/12/19
06:12
Recommendations
Allegiant Travel analyst commentary  »

Allegiant Travel price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AER

AerCap

$60.29

-0.31 (-0.51%)

06:09
11/12/19
11/12
06:09
11/12/19
06:09
Recommendations
AerCap analyst commentary  »

AerCap price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

WU

Western Union

$27.35

-0.52 (-1.87%)

06:09
11/12/19
11/12
06:09
11/12/19
06:09
Downgrade
Western Union rating change  »

Western Union downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBS

UBS

$12.41

-0.01 (-0.08%)

06:07
11/12/19
11/12
06:07
11/12/19
06:07
Hot Stocks
UBS fined by Hong Kong regulator for overcharging clients »

Hong Kong's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

HLX

Helix Energy

$8.56

0.03 (0.35%)

06:07
11/12/19
11/12
06:07
11/12/19
06:07
Initiation
Helix Energy initiated  »

Helix Energy reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

FENC

Fennec

$5.24

0.13 (2.54%)

06:06
11/12/19
11/12
06:06
11/12/19
06:06
Earnings
Fennec reports Q3 EPS (9c), consensus (20c) »

Cash and cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDNT

RadNet

$16.14

0.09 (0.56%)

06:06
11/12/19
11/12
06:06
11/12/19
06:06
Hot Stocks
Breaking Hot Stocks news story on RadNet »

RadNet raises FY19 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

KBR

KBR

$29.63

0.44 (1.51%)

06:05
11/12/19
11/12
06:05
11/12/19
06:05
Hot Stocks
KBR ROSE technology selected for modernization project at India refinery »

KBR announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

RDNT

RadNet

$16.14

0.09 (0.56%)

06:05
11/12/19
11/12
06:05
11/12/19
06:05
Earnings
RadNet backs FY19 revenue view $1.1B-$1.15B, consensus $1.13B »

Backs FY19 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

OII

Oceaneering

$13.99

-0.29 (-2.03%)

06:05
11/12/19
11/12
06:05
11/12/19
06:05
Initiation
Oceaneering initiated  »

Oceaneering initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DYNT

Dynatronics

$0.84

0.0296 (3.65%)

06:04
11/12/19
11/12
06:04
11/12/19
06:04
Earnings
Breaking Earnings news story on Dynatronics »

Dynatronics backs FY20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 19

    Nov

  • 04

    Dec

NOG

Northern Oil and Gas

$2.06

-0.07 (-3.29%)

06:04
11/12/19
11/12
06:04
11/12/19
06:04
Hot Stocks
Northern Oil and Gas sees FY19 production 38,750BOE-39,150BOE per day »

Sees FY19 production…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 19

    Nov

  • 20

    Nov

RDNT

RadNet

$16.14

0.09 (0.56%)

06:04
11/12/19
11/12
06:04
11/12/19
06:04
Earnings
RadNet reports Q3 adjusted EPS 8c, consensus 10c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

EPC

Edgewell Personal Care

$36.46

-0.81 (-2.17%)

06:03
11/12/19
11/12
06:03
11/12/19
06:03
Earnings
Edgewell Personal Care reports Q4 adj. EPS 86c, consensus 84c »

Reports Q4 revenue $528M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

DYNT

Dynatronics

$0.84

0.0296 (3.65%)

06:03
11/12/19
11/12
06:03
11/12/19
06:03
Earnings
Dynatronics reports Q1 EPS (1c), consensus (4c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 19

    Nov

  • 04

    Dec

NHI

National Health Investors

$79.95

0.62 (0.78%)

06:02
11/12/19
11/12
06:02
11/12/19
06:02
Hot Stocks
National Health Investors names John Spaid as CFO, effective November 8 »

National Health Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

NOG

Northern Oil and Gas

$2.06

-0.07 (-3.29%)

06:02
11/12/19
11/12
06:02
11/12/19
06:02
Earnings
Northern Oil and Gas reports Q3 adjusted EPS 9c, consensus 11c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 19

    Nov

  • 20

    Nov

06:02
11/12/19
11/12
06:02
11/12/19
06:02
General news
NFIB Small Business Optimism Index level data reported »

October NFIB Small…

FGEN

FibroGen

$35.37

-6.24 (-15.00%)

05:59
11/12/19
11/12
05:59
11/12/19
05:59
Recommendations
FibroGen analyst commentary  »

FibroGen should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.